heavy chain deposition disease in kidney biopsies alenka vizjak, jerica mraz, jelka lindič, dušan...

18
Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University of Ljubljana, Slovenia Disclosures: no conflicts of interest

Upload: rudolph-parker

Post on 18-Jan-2016

219 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

Heavy chain deposition disease in kidney biopsies

Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga

Institute of Pathology, Faculty of Medicine University of Ljubljana, Slovenia

Disclosures: no conflicts of interest

Page 2: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

Heavy chain deposition disease

(HCDD) • HCDD - a rare monoclonal immunoglobulin-

related disorder of not yet fully explored pathogenesis

• Characterized by production and systemic deposition of structurally abnormal immunoglobulin heavy chains, while light chains absent in the deposits

• First described by Aucouturier et al(N Engl J Med 1993; 329: 1389-93)

Page 3: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

Monoclonal immunoglobulin deposits in the kidney

Amyloid deposits

Non-amyloid monoclonal immunoglobulin deposits

Amyloidosis LC

HC (very rare)

MIDD Randall-type

LCDD

LHCDD

HCDD

GN with monoclonal Igs dps mimicking IC-GN

Cryoglobulinemic-GN

Immunotactoid GP / fibrillary GN

Page 4: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

Patients and methods

• 4 biopsy cases of HCDD (5 kidney biopsies; 1 autopsy), representing 0.09% prevalence among 5481 native kidney biopsies

• All 4 female patients, age range 62 – 79 yrs, mean age 73.0 yrs

• Standard light microscopy• Immunofluorescence microscopy

IgA, IgG, IgM, κ, λ, C3, C1q, fibrin/fibrinogen, albuminIgG1, IgG2, IgG3, IgG4, γCH1, γCH2, γCH3

• Electron microscopy

Page 5: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

Clinical presentation / diagnosis in 4 patients with HCDD

Pts At kidney biopsy After kidney biopsy

PM - 1st CKD, prot, compl↓ no dysproteinemia

PM - 2nd CKD, NS, compl↓ no dysproteinemia

JA CKD, prot, compl↓ plasmocytoma

BŠ RPGN, NS, compl↓ plasmocytoma

RM CKD, nephr prot, compl norm

no dysproteinemia

CKD – chronic kidney disease, NS – nephrotic syndrome

Page 6: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

Immunofluorescence microscopy in 4 cases of HCDD

Pts IgG (γ)

IgGsubclass

γCH1 γCH2γCH3

κ / λ C3 C1q

PM - 1st 4+ n.d. n.d. n.d. 2+ / ± 2+ 4+

PM - 2nd 4+ IgG3 0 4+ 0 / 0 2+ 4+

JA 3+ IgG3 0 3+ 0 / 0 4+ 3+

BŠ 4+ IgG3 0 4+ 0 / 0 3+ 4+

RM 4+ IgG1 0 4+ 0 / 0 4+ 3+

Page 7: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

Light and electron microscopy in 4 cases with HCDD

Light microscopy•Diffuse nodular glomerulosclerosis 4/4•Glomerular capillary aneurysms 4/4•Mesangial proliferation, 4/4with segm endo-, membranoprol pattern 3/4•Extracapillary crescents (few) 2/4

Electron microscopy•Punctate and powdery electron dense deposits 3/4

Page 8: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

IgG (γ heavy chain) κ, λ light chains

Page 9: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

IgG (γ heavy chain)

Page 10: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

IgG1 IgG2

Page 11: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

C3 C1q

Page 12: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

γCH1 γCH2

Page 13: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University
Page 14: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University
Page 15: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

SMA+CD31 CD68

Page 16: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University
Page 17: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University
Page 18: Heavy chain deposition disease in kidney biopsies Alenka Vizjak, Jerica Mraz, Jelka Lindič, Dušan Ferluga Institute of Pathology, Faculty of Medicine University

Conclusions of our study

• Immunofluorescence examination of kidney biopsy, including testing for Igs heavy and light chains, as well as IgG subclasses, is crucial for the diagnosis of HCDD.

• Our study showed that HCDD is peculiar among MIDD because of uniform pattern of nodular glomerulosclerosis with pronounced capillary aneurysms and significant proliferation due to complement activation.

• Constant deletion of the gamma heavy chain CH1 domain and its significance in the pathogenesis of HCDD was confirmed.